Duker Speaks to Cost Concerns, Other Challenges Facing Retina (OIS@ASRS - 2016)

Jay S. Duker, MD, is the Director of the New England Eye Center (NEEC), Professor and Chairman of Ophthalmology at Tufts Medical Center and Tufts University School of Medicine, is seeing much-needed increases in innovation for retinal disease, suggesting we’re at the “end of the beginning” of an epic rise in innovation. “I think we’ve just started to recognize the power of [diagnostics and imaging],” he tells OIS-TV. “We’ve learned that one pathway, the VEGF pathway is really a final common denominator for a lot of diseases. And I think that we may see other pathways, programmed cell death pathways and other things that we’re able to successfully treat and block a myriad.” Duker talks about innovation, paying for new treatments and his own gene therapy start-up.

For more on Ophthalmology Innovation News & Events visit: